Skip to main content
Premium Trial:

Request an Annual Quote

Tackling HIV From All Ends

Infectious disease researchers led by Anthony Fauci at the National Institute of Allergy and Infectious Diseases have found what they've determined to be a new receptor molecule for HIV, reports the New York Times. Adding another one to the arsenal of potential HIV drug targets, they found that integrin alpha-4 beta-7, which naturally directs immune cells to the gut, is also a receptor for the virus. It works by binding to the virus and guiding it to the gut. "They begin to shed light on the mysterious process on why the virus preferentially grows in the gut," Warner C. Greene, an AIDS expert, is quoted as saying.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.